Blog - Page 4143 of 5482

MondayNov 03, 2008 6:40 am

GeoResources, Inc. (NASDAQ: GEOI)

GeoResources, Inc. (NASDAQ: GEOI) owns and operates producing oil and gas properties in the Gulf Coast, Permian Basin, Rocky Mountains and Williston Basin through its three subsidiaries G3 Operating, LLC and Southern Bay Operating, LLC. The company leverages its management’s expertise in mergers and acquisitions, which is further enhanced by relationships with investment and commercial bankers, institutional investors, brokers and principals. For further information, visit the Company's web site at www.georesourcesinc.com.

MondayNov 03, 2008 6:39 am

Geologix Explorations Inc. (TSX: GIX CN)

Geologix Explorations Inc. (TSX: GIX CN), a mineral exploration company, is committed to acquiring, exploring and developing gold properties in North and South America, as well as Mexico. Their projects include: San Agustin, La Casita, Consejo, Silver Cloud, QC Property, RO Property, OZ Property, Geologix-Newmont Alliance, Liscay Property, Cayhua, San Felipe, Sura, Patcorral, and Toro Blanco. The Company’s management has extensive expertise in the mining industry and have track record of brning early stage exploration prospects to final feasibility and ultimately to production. For further information, visit the Company's web site at http://www.geologix.ca.

MondayNov 03, 2008 6:39 am

Gentium S.p.A. (NASDAQ: GENT)

Gentium S.p.A. (NASDAQ: GENT), a biopharmaceutical company, specializes in discovering, researching, developing and manufacturing active ingredients derived from natural sources as potential therapeutic agents. The company focuses on developing relationships with industrial and academic institutions and intends to discover further beneficial effects of its products as well as develop pharmaceuticals with a broader range of treatment indications. For further information, visit the Company's web site at http://www.gentium.com.

MondayNov 03, 2008 6:39 am

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), a biopharmaceutical company, focuses on developing and commercializing a varied, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs. The company’s business strategy is to utilize new insights from molecular and cancer biology to understand the effectiveness and safety limitations of approved and developmental cancer therapies and identify proprietary and related molecules for better patient treatment. For further information, visit the Company's web site at www.ziopharm.com.

MondayNov 03, 2008 6:38 am

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC)

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC) is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Genesis is a major pharmaceutical company in China producing tablets, capsules, and granules for both western and Chinese herbal- based medical drugs. The company has recently appointed Michael Marks to its Board of Directors and is looking to capitalize on the international pharmaceutical market.

MondayNov 03, 2008 6:38 am

ZBB Energy Corporation (AMEX: ZBB)

ZBB Energy Corporation (AMEX: ZBB), a leading innovator of energy storage systems, is focused on providing energy storage systems to utility companies, industrial and commercial organizations and renewable energy generators. The company’s aim is to develop and produce products that increase energy efficiency, minimize the impact on the environment and maximize the use of renewable energy. Founded in 1981, ZBB is headquartered in Wisconsin with offices located in Perth, Australia. For further information, visit the Company's web site at www.zbbenergy.com.

MondayNov 03, 2008 6:38 am

Generex Biotechnology Corporation (NASDAQ: GNBT)

Generex Biotechnology Corporation (NASDAQ: GNBT), a biopharmaceutical company, has a diversified product portfolio designed to deliver innovative products to treat patients with cancer. DNA/RNA-based Medicines and Small Molecules are the two major programs that anchor the Company's research platform. Ganite® (gallium nitrate injection) is the company’s leading drug in the Small Molecule program. Ganite is exclusively marketed in the U.S. to treat symptomatic patients with cancer-related hypercalcemia that is resistant to hydration. For further information, visit the Company's web site at www.genta.com.

MondayNov 03, 2008 6:37 am

YM BioSciences, Inc. (AMEX: YMI)

YM BioSciences, Inc. (AMEX: YMI), an oncology company, is focused on identifying, developing and commercializing a variety of products for patients on a global basis. The Company is advancing two late-stage products: Nimotuzumab, a humanized monoclonal antibody designed to target the epidermal growth factor receptor (EGFR); and AeroLEF®, a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. Nimotuzumab has received approval in multiple countries for treating types of head and neck cancer, while AeroLEF is in development for the treatment of moderate to severe pain. For further information, visit the Company's web site at www.ymbiosciences.com.

MondayNov 03, 2008 6:37 am

Genco Resources Ltd. (TSX: GGC CN)

Genco Resources Ltd. (TSX: GGC CN), a junior silver mining company, has its core assets in a number of mining sites including the La Guitarra Mine. This mine is located within the Sierra Madre silver and gold Metallogenic Province that has historically produced some of the world's most extraordinary mines. The La Guitarra Mine produces precious metals from a classic epithermal vein system, part of a mineralized corridor that measures 15 kilometers in length and averages 4 kilometers in width. For further information, visit the Company's web site at www.gencoresources.com.

MondayNov 03, 2008 6:37 am

Xsunx, Inc. (OTC BB: XSNX)

Xsunx, Inc. (OTC BB: XSNX), a thin-film photovoltaic (“TFPV”) company, is focused on executing a phased plan to build and install 100 mega-watts (MW) of amorphous silicon (“a-Si”) thin film solar module manufacturing capacity. XsunX has designed its TFPV product to service a wide range of installation environments and deliver performance characteristics that address the needs of solar farm and utility grade applications. For further information, visit the Company's web site at www.xsunx.com.

Site Search

Company Search

GeoResources, Inc. (NASDAQ: GEOI)

Geologix Explorations Inc. (TSX: GIX CN)

Gentium S.p.A. (NASDAQ: GENT)

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)

Genesis Pharmaceuticals Enterprises, Inc. (OTC BB: GTEC)

ZBB Energy Corporation (AMEX: ZBB)

Generex Biotechnology Corporation (NASDAQ: GNBT)

YM BioSciences, Inc. (AMEX: YMI)

Genco Resources Ltd. (TSX: GGC CN)

Xsunx, Inc. (OTC BB: XSNX)

Market Basics

Newsletter Publishers

Public Companies